BiotechTube
Home/Asher Biotherapeutics/Ivana Djuretic, PhD
ID

Ivana Djuretic, PhD

Founder, Chief Executive Officer

Asher Biotherapeutics

Therapeutic Areas

OncologyInfectious Diseases

Asher Biotherapeutics Pipeline

DrugIndicationPhase
Etakafusp alfa (AB248)Recurrent locally advanced or metastatic solid tumors (Melanoma, RCC, NSCLC, SCCHN)Phase 1a/1b
AB821Oncology (Solid Tumors)Preclinical
Undisclosed Cis-Targeted ProgramsOncology & Infectious DiseasesPreclinical

Leadership Team at Asher Biotherapeutics

EG
Edward Garmey, MD
Consulting Chief Medical Officer
View full Asher Biotherapeutics profile